Identification of Brd4 as a novel regulator of H. pylori-induced apoptosis resistance provides not only new insights into the pathogenesis of H. pylori infection but also provides potential alternative approaches by targeting Brd4 for the prevention and treatment of H. pylori-associated gastric cancer and drug-resistance. This evidence concerns the gene BRD4 and gastric cancer.